4.2 Article

Mutations in the embB locus among Korean clinical isolates of Mycobacterium tuberculosis resistant to ethambutol

期刊

YONSEI MEDICAL JOURNAL
卷 43, 期 1, 页码 59-64

出版社

YONSEI UNIV COLLEGE MEDICINE
DOI: 10.3349/ymj.2002.43.1.59

关键词

M. tuberculosis; ethambutol resistance; embB mutations

向作者/读者索取更多资源

Resistance of Mycobacterium tuberculosis to ethambutol (ENS) has been assigned to an operon, embCAB, which has been proposed to be a structural gene for mycobacterial arabinosyl transferases. Recently, genetic events resulting in structural mutations at embB have been proposed as major contributors to the ENS-resistance of isolates whose minimum inhibitory concentration (MIC) level is higher than 20 mug/ml. On the contrary, isolates with a MIC level lower than 20 mug/ml do not seem to contain any sequence alterations. In this study, in an effort to understand the role of embB mutations at a low-level of ENS resistance, we investigated the sequence polymorphisms of clinical isolates whose MIC levels are lower than 10 mug/ml. Accordingly, the sequence alterations of a 312-bp region of the embB gene containing the 306(th) codon, which has been assigned as a hot-spot for ENM-resistance related mutations, were determined for 21 EMB-resistant and 5 EMB-susceptible clinical isolates. In brief, among 21 EMB-resistant isolates examined, 12 (57.1%) contained mutations in embB (10 at the 306th codon and 2 at other sites), and the remaining isolates 9 contained no mutations in any region of embB. The observed mutations included M306V, M306I, and M306L substitutions that have been reported previously. However, 3 were novel types, which included M306T, A313G and Y322C, D331Y double substitutions. On the other hand, all of the EMB-susceptible isolates were found to be free of mutations. In conclusion, our findings suggest that sequence polymorphism. of embB may play a pivotal role in the EMB-resistance of M.:tuberculosis.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据